CD20 negativity at the start of second-line therapy predicts a shorter overall survival in B-cell lymphomas
二线治疗开始时CD20阴性预示着B细胞淋巴瘤患者的总生存期较短。
期刊:
影响因子:
doi:10.1016/j.bneo.2026.100219
Gholy, Sanaz Mehdi; Ranadóttir, Torgerð; Davidsson, Olafur Birgir; Kristjánsson, Ragnar Pétur; Kadlec, Tereza Fait; Vainer, Noomi; Katsimigas, Andreas; Werling, Mikkel; Kyvsgaard, Emil; Husby, Simon; da Cunha-Bang, Caspar; Rostgaard, Klaus; Hutchings, Martin; Brown, Peter; Hjalgrim, Henrik; Niemann, Carsten Utoft; Brieghel, Christian; Dietz, Jojo Biel-Nielsen
